The development of antiretroviral therapy for the prevention and treatment of HIV infection
has been marked by a series of remarkable successes. However, the efforts to develop a …

Rates of sexually transmitted infections (STIs) continue to rise across the world and
interventions are essential to reduce their incidence. Past and recent studies have indicated …

Abstract Purpose of Review We reviewed the available literature on mpox in People with
HIV (PWH). We highlight special considerations of mpox infection related to epidemiology …

The economic burden of HIV extends beyond the individual level and affects communities
and countries. HIV can lead to decreased economic growth due to lost productivity and …

Background Integrase strand transfer inhibitors (INSTIs) have been associated with an
increased risk for cardiovascular disease (CVD) events. We investigated the impact of …

Background Long-acting (LA) injectable therapy with cabotegravir (CAB) and rilpivirine
(RPV) is currently used as maintenance treatment for human immunodeficiency virus type 1 …

The current prevention efforts for STIs, HIV and viral hepatitis in the WHO European Region,
especially in the Central and Eastern subregions, are hindered by healthcare disparities …

Background There are few data assessing the uptake of first-line dolutegravir among men
and women living with HIV in low-income and middle-income countries, and subsequent …

Background: Dolutegravir (DTG)-based antiretroviral therapy (ART) rarely leads to
virological failure (VF) and drug resistance in integrase strand transfer inhibitor (INSTI)-naïve …

Rapid advances in the potency, safety, and availability of modern HIV antiretroviral therapy
(ART) have yielded a near-normal life expectancy for most people living with HIV (PLWH) …